Other languages Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:37:48 2024-05-31 am EDT			5-day change	1st Jan Change
89.76 ^EUR	+1.34%		+0.27%	-.--%

May. 31	CAC40: at the 8000 pts threshold, loses nearly 1.3% over the week	CF
May. 31	CAC40: remains at equilibrium despite sharp decline in Nasdaq and S&P	CF

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CAC40 : au seuil des 8000 pts, cède près de 1,3% en hebdo	May. 31
CAC40 : reste à l'équilibre malgré net repli du Nasdaq et S&P	May. 31
CAC40 : le mois de mai s'achève sans tendance, sur score nul	May. 31
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review	May. 31
Sanofi, Regeneron's Dupixent Receives Recommendation for Approval From European Medicines Agency Committee	May. 31
Sanofi : lancement du plan d'actionnariat salarié 2024	May. 31
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	May. 31
CAC40 : tendance stable avant l'inflation américaine	May. 31
Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months	May. 31
Sanofi : avis favorable du CHMP dans la BPCO	May. 31
CAC40 : biais légèrement positif avant l'ouverture	May. 31
US FDA Delays Decision on Sanofi, Regeneron's Lung Disease Treatment Dupixent	May. 31
Sanofi, Regeneron's Lung Disease Treatment Recommended for EU Approval	May. 31
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.	May. 31
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD	May. 31
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation	May. 31
Regeneron Pharmaceuticals, Inc and Sanofi Announces Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation	May. 31
CAC40 : reprend un peu d'altitude, Airbus en soutien	May. 30
Sanofi Closes Purchase of US Biotech Company Inhibrx	May. 30
Largest vaccine production plant in Canada opens in Toronto	May. 30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST